C12N 2710/16371
Demonstrated in vivo effect
C12N2710/16371 (Demonstrated in vivo effect) appears on 5 US grants and 9 published applications in this corpus.
Search patents in C12N- Granted patents
- 5
- Published applications
- 9
- Assignees
- 4
- Inventors
- 8
- Latest grant
- 7 Feb 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 1 |
| 2017 | 0 | 1 |
| 2018 | 0 | 0 |
| 2019 | 1 | 1 |
| 2020 | 2 | 1 |
| 2021 | 0 | 2 |
| 2022 | 1 | 0 |
| 2023 | 1 | 0 |
| 2024 | 0 | 1 |
By publication year.
Recent patents
- Vaccine compositions of herpesvirus envelope protein combinations to induce immune response7 Feb 2023US 11,572,389 B2The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
- Recombinant turkey herpesvirus vaccines and uses thereof6 Sep 2022US 11,433,130 B2The Texas A&M University System
- Recombinant turkey herpesvirus vaccines and uses thereof27 Oct 2020US 10,813,991 B2The Texas A&M University System
- Recombinant turkey herpesvirus vaccines and uses thereof21 Jan 2020US 10,537,628 B2The Texas A&M University System
- Recombinant Marek's disease viruses and uses thereof29 Jan 2019US 10,188,720 B2Ceva Sante Animale
- Vaccine compositions of herpesvirus envelope protein combinations to induce immune response15 Aug 2024US 2024/0270796 A1The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
- Vaccine compositions of herpesvirus envelope protein combinations to induce immune response3 Jun 2021US 2021/0163542 A1The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
- Recombinant turkey herpesvirus vaccines and uses thereof1 Apr 2021US 2021/0093710 A1The Texas A&M University System
- Recombinant turkey herpesvirus vaccines and uses thereof14 May 2020US 2020/0147200 A1The Texas A&M University System
- Vaccine compositions of herpesvirus envelope protein combinations to induce immune response5 Dec 2019US 2019/0367561 A1The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
Most cited
By later US patents
- Recombinant Marek's disease viruses and uses thereof4US 10,188,720 B2Ceva Sante Animale · 2019
- Recombinant turkey herpesvirus vaccines and uses thereof4US 10,813,991 B2The Texas A&M University System · 2020
- Recombinant turkey herpesvirus vaccines and uses thereof1US 10,537,628 B2The Texas A&M University System · 2020